Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
4(80.0%)
N/A
1(20.0%)
5Total
Phase 2(4)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01653184Not ApplicableCompleted

Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration

Role: collaborator

NCT02260973Phase 2Unknown

The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity

Role: lead

NCT02497560Phase 2Terminated

A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms

Role: lead

NCT02333084Phase 2Unknown

The Influence Of a Natural Anti-Inflammatory Product On Levels Of Inflammatory Markers In Cases With Osteoarthritis Of Knee

Role: lead

NCT02260960Phase 2Completed

The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease

Role: lead

All 5 trials loaded